• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4624134)   Today's Articles (172)   Subscriber (49411)
Download
Number Citation Analysis
76
Iacobucci I, Ferrari A, Lonetti A, Papayannidis C, Paoloni F, Abbenante M, Guadagnuolo V, Ottaviani E, Cattina F, Vitale A, Paolini S, Soverini S, Parisi S, Vignetti M, Baccarani M, Martinelli G. The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6532] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
77
Fill C, Finelli C, Gobbi M, Martinelli G, Iacobucci I, Ottaviani E, Cocco L, Matilde F, Candoni A, Simeone E, Miglino M, Lauria F, Bocchia M, Defina M, Clissa C, Lanza F, Spedini P, Skert C, Bergonzi C, Malagola M, Peli A, Turra A, Cattina F, Colombi C, Russo D. 216 Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study. Leuk Res 2011. [DOI: 10.1016/s0145-2126(11)70218-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
78
Follo M, Mongiorgi S, Clissa C, Filì C, Colombi C, Baccarani M, Martinelli G, Gobbi M, Manzoli L, Russo D, Finelli C, Cocco L. 240 Effect of azacitidine on inositide-dependent signalling pathways in low-risk MDS patients. Leuk Res 2011. [DOI: 10.1016/s0145-2126(11)70242-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
79
Ghirardini A, Nanni-Costa A, Venturi S, Ridolfi L, Petrini F, Taddei S, Venturoli A, Pugliese MR, Monti M, Martinelli G. Efficiency of organ procurement and transplantation programs. Transpl Int 2011. [DOI: 10.1111/j.1432-2277.2000.tb02034.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
80
Laszlo D, Andreola G, Rigacci L, Fabbri A, Rabascio C, Pinto A, Negri M, Martinelli G. Rituximab and Subcutaneous 2-Chloro-2′-Deoxyadenosine as Therapy in Untreated and Relapsed Waldenström's Macroglobulinemia. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2011;11:130-2. [DOI: 10.3816/clml.2011.n.029] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
81
Martinelli G, Cocorocchio E, Saletti PC, Orecchia R, Bernier J, Tradati N, Santoro P, Robertson C, Peccatori FA, Zucca E, Cavalli F. Efficacy of Vinblastine, Bleomycin, Methotrexate (VBM) Combination Chemotherapy with Involved Field Radiotherapy in Early Stage (I-IIA) Hodgkin Disease Patients. Leuk Lymphoma 2010;44:1919-23. [PMID: 14738143 DOI: 10.1080/1042819031000123429] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
82
Angelini S, Turrini E, Ravegnini G, Soverini S, Martinelli G, Kalebic T, Barnett M, Hrelia P. A pharmacogenetic approach towards personalised anti-cancer drug use. J Biotechnol 2010. [DOI: 10.1016/j.jbiotec.2010.08.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
83
Sessa C, Martinelli G, Hess D, Delmonte A, Noberasco C, Sammassimo S, Gallerani E, Marsoni S, Camboni G, de Braud F. 379 A first in human phase I study of the proteasome inhibitor CEP-18770 in patients (pts) with advanced solid tumors, non-Hodgkin's lymphomas (NHL) and multiple myeloma (MM). EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)72086-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]  Open
84
Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJM, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F, Zucca E. Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol 2010;22:689-695. [PMID: 20810546 DOI: 10.1093/annonc/mdq416] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]  Open
85
Martinelli G, Paolini S, Papayannidis C, Ottaviani E, Parisi S, Iacobucci I, Curti A, Cilloni D, Saglio G, Candoni A, Baccarani M. Correlation of RASGRP1/APTX ratio with clinical response and survival in AML patients treated with tipifarnib-bortezomib combination. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
86
Kim D, Saglio G, Martinelli G, Shou Y, Stein AM, Woodman RC, Kantarjian H, Hughes TP, Radich JP, Hochhaus A. BCR-ABL transcript analysis of patients (pts) with imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
87
Soverini S, Angelini S, Barnett M, Thornquist M, Turrini E, Rosti G, Hrelia P, Kalebic T, Baccarani M, Martinelli G. Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia (CML) patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6554] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
88
Iacobucci I, Ferrarini A, Sazzini M, Lonetti A, Giacomelli E, Xumerle L, Ferrari A, Papayannidis C, Delledonne M, Martinelli G. Use of deep whole transcriptome sequencing in Philadelphia-positive acute lymphoblastic leukemia (ALL) to identify novel mutated genes and aberrant gene expression and alternative splicing profiles associated with disease progression. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
89
Pierz KA, Gu S, Lewis ME, Hsu S, Falandry C, Salles GA, Fey MF, Martinelli G, Hitz F, Ghielmini ME. Predictive value of FCGR3A genotype on response to rituximab induction and maintenance therapy (MT) in follicular non-Hodgkin's lymphoma (NHL). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8065] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
90
Hochhaus A, Saglio G, Kantarjian H, Haque A, Shou Y, Woodman RC, Hughes TP, Radich JP, Martinelli G, Kim D. Detection of new mutations in patients (pts) with imatinib-resistant chronic myeloid leukemia in chronic phase (CML-CP) treated with nilotinib. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
91
Branford S, Martinelli G, Saglio G, Kim D, Shou Y, Reynolds J, Woodman RC, Kantarjian H, Hochhaus A, Radich JP. Association of early molecular response to nilotinib with probability of cytogenetic response in chronic myeloid leukemia patients (pts) who fail imatinib. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6513] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
92
Rosti G, Castagnetti F, Palandri F, Poerio A, Soverini S, Breccia M, Pane F, Martinelli G, Baccarani M, Saglio G. Efficacy and safety of nilotinib 800 mg daily in early chronic phase Ph+ chronic myeloid leukemia: Results of a phase II trial at 2 years. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6515] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
93
Curigliano G, Spitaleri G, Magni E, Lorizzo K, De Cobelli O, Locatelli M, Fumagalli L, Adamoli L, Cossu Rocca M, Verri E, De Pas T, Jereczek-Fossa B, Martinelli G, Goldhirsch A, Nolè F. Cisplatin, etoposide and continuous infusion bleomycin in patients with testicular germ cell tumors: efficacy and toxicity data from a retrospective study. J Chemother 2010;21:687-92. [PMID: 20071294 DOI: 10.1179/joc.2009.21.6.687] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
94
Cilloni D, Carturan S, Maffè C, Messa F, Arruga F, Messa E, Pradotto M, Pautasso M, Zanone C, Fornaciari P, Defilippi I, Rotolo A, Greco E, Iacobucci I, Martinelli G, Lo-Coco F, Bracco E, Saglio G. WITHDRAWN: Proteinase 3 (PR3) gene is highly expressed in CBF leukemias and codes for a protein with abnormal nuclear localization that confers drug sensitivity. Leukemia 2010:leu2009207. [PMID: 20072158 DOI: 10.1038/leu.2009.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
95
Agazzi A, Sammassimo S, Laszlo D, Liptrott SJ, Cascio R, Alietti A, Rabascio C, Mancuso P, Pruneri G, Martinelli G. Is there a role for 'modified VAD' in the treatment of multiple myeloma? Ecancermedicalscience 2010;3:136. [PMID: 22276003 PMCID: PMC3223996 DOI: 10.3332/ecancer.2009.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2009] [Indexed: 11/06/2022]  Open
96
Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, Calabrese L, Pruneri G, Santoro L, Kuper-Hommel M, Tsang R, Zinzani PL, Taghian A, Zucca E, Cavalli F. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2009;20:1993-9. [PMID: 19570964 DOI: 10.1093/annonc/mdp238] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]  Open
97
Hitz F, Martinelli G, Zucca E, von Moos R, Mingrone W, Simcock M, Peterson J, Cogliatti SB, Bertoni F, Zimmermann DR, Ghielmini M. A multicentre phase II trial of gemcitabine for the treatment of patients with newly diagnosed, relapsed or chemotherapy resistant mantle cell lymphoma: SAKK 36/03. Hematol Oncol 2009;27:154-9. [PMID: 19274614 DOI: 10.1002/hon.891] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
98
Laszlo D, Pruneri G, Andreola G, Radice D, Calabrese L, Rafaniello PR, Nassi L, Sammassimo S, Alietti A, Agazzi A, Vanazzi A, Martinelli G. Tissue microarrays in diffuse large B-cell lymphomas: are they really able to identify distinct prognostic groups in lymphomas of both nodal and extranodal origin? Int J Surg Pathol 2009;19:417-24. [PMID: 19793830 DOI: 10.1177/1066896909345596] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
99
Martinelli G, F S, Schmitz H, Hess U, Okkinga E, Stupp R, Taverna C, Vorobiof D, Heizmann M, Dietrich P, Ghielmini M. 9206 Long-term follow-up of follicular lymphoma (FL) patients receiving single agent rituximab at two different schedules in trial SAKK 35/98. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71897-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
100
Vanazzi A, Pruneri G, Crosta C, Grana C, Rizzo S, Radice D, Steffanoni S, Pinto A, Paganelli G, Martinelli G. 9207 Efficacy of 90Yttrium-ibritumomab tiuxetan in extranodal marginal-zone lymphoma. EJC Suppl 2009. [DOI: 10.1016/s1359-6349(09)71898-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]  Open
PrevPage 4 of 24 123452324Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA